medication compliance
Medications
Instructed in new medication Sinemet and in S/E such as choreiform, dystonic, dyskinetic movements, involuntary grimacing, head movements, myoclonic body jerks, ataxia, tremor, muscle twitching, bradykinetic episodes, psychiatric disturbances, anxiety, disturbing dreams, euphoria, malaise, fatigue, severe depression, suicidal tendencies, dementia, delirium, hallucinations (may necessitate reduction or withdrawal of drug), confusion, insomnia, agitation, orthostatic hypotension, cardiac irregularities, phlebitis, blepharospasm, blurred vision, diplopia, mydriasis or miosis, oculogyric crises, excessive salivation, dry mouth, bitter taste, nausea, vomiting, anorexia, constipation, flatulence, diarrhea, abdominal pain, urinary frequency, urine retention, urinary incontinence, darkened urine, priapism, hemolytic anemia, thrombocytopenia, leukopenia, agranulocytosis, hepatotoxicity, weight loss (may occur at start of therapy), hiccups, hyperventilation, and dark perspiration.
Instructed in new medication Singulair and in S/E such as headache, dizziness, fatigue, asthenia, fever, nasal congestion, dental pain, dyspepsia, infectious gastroenteritis, abdominal pain, pyuria, cough, rash, trauma, and influenza.
Instructed in new medication Advair diskus to manage asthma. In addition, warned of possible S/E such as sleep disorders, tremor, hypnagogic effects, compressed nerve syndromes, headache, pain, palpitations, pharyngitis, sinusitis, hoarseness (or dysphonia), rhinorrhea, rhinitis, sneezing, nasal irritation, blood in nasal mucosa, keratitis, conjunctivitis, eye redness, viral eye infections, congestion, nausea, vomiting, abdominal pain and discomfort, diarrhea, gastroenteritis, oral discomfort and pain, constipation, oral ulcerations, oral erythema and rashes, oral candidiasis, appendicitis, dental discomfort and pain, unusual taste, muscular pain, arthralgia, articular rheumatism, muscle stiffness, tightness, rigidity, bone and cartilage disorders, upper respiratory tract infection, upper respiratory tract inflammation, lower respiratory tract viral infection, bronchitis, cough, pneumonia, urticaria, flakiness, disorders of sweat and sebum, sweating, hives, viral infections, chest symptoms, fluid retention, bacterial infections, allergic reactions.
Instructed in new medication Prednisone and in S/E such as euphoria, insomnia, psychotic behavior, vertigo, headache, paresthesia, seizures, pseudotumor cerebri, heart failure, hypertension, edema, arrhythmias, thrombophlebitis, thromboembolism, cataracts, glaucoma, peptic ulceration, GI irritation, increased appetite, pancreatitis, nausea, vomiting, menstrual irregularities, increased urine calcium levels, hypokalemia, hyperglycemia, carbohydrate intolerance, growth suppression in children, muscle weakness, osteoporosis, hirsutism, delayed wound healing, acne and various skin eruptions.
Instructed in new medication Augmentin to manage infection. In addition, warned of possible S/E such as nausea, vomiting, headache, dizziness, skin rash, blurred vision, confusion, anxiety, redness, etc.
Instructed in new medication Allegra to manage allergic rhinitis. In addition, warned of possible S/E such as fatigue, drowsiness, nausea, dyspepsia, dysmenorrhea, and viral infection.
Instructed in new medication Xopenex to manage bronchospasm. In addition, warned of possible S/E such as dizziness, migraine, pain, tremor, anxiety, tachycardia, dyspepsia, leg cramps, increased cough, flu syndrome, accidental injury and viral infection.
Instructed in new medication Feroso to manage anemia. In addition, warned of possible S/E such as nausea, vomiting, constipation, GI discomfort, headache, dizziness, dry mouth, rash and others.
Instructed in new medication Actos to improve glycemic control. In addition, warned of possible S/E such as headache, edema, heart failure, sinusitis, pharyngitis, tooth disorder, anemia, hypoglycemia (with combination therapy), aggravated diabetes mellitus, weight gain, myalgia and upper respiratory tract infection.
Instructed in new medication Starlix to manage diabetes. In addition, warned of possible S/E such as dizziness, diarrhea, hypoglycemia, back pain, arthropathy, upper respiratory tract infection, bronchitis, coughing, flu symptoms and accidental trauma. Instructed to take drug 1 to 30 minutes before a meal. Notify MD for persistent hypoglycemia or hyperglycemia.